missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ L-Myc Monoclonal Antibody (803017)
Mouse Monoclonal Antibody
Brand: Invitrogen™ MA561378
This item is not returnable.
View return policy
Description
Reconstitute at 0.5 mg/mL in sterile PBS.
Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. L-Myc gene ontology annotations include DNA binding function, DNA-binding transcription factor activity, RNA polymerase II-specific action, protein dimerization activity, and regulation of inner ear auditory receptor cell differentiation.
Specifications
| L-Myc | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with trehalose and no preservative | |
| P12524 | |
| MYCL | |
| E. coli-derived recombinant human MYCL1/L-Myc, Gly16-Asn139. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG2b |
| ELISA | |
| 803017 | |
| Unconjugated | |
| MYCL | |
| Avian myelocytomatosis viral (v-myc) related oncogene homolog 1, lung carcinoma derived (Lmyc); AW536278; bHLHe38; Class E basic helix-loop-helix protein 38; LMYC; L-MYC; Lmyc1; Lmyc-1; l-myc-1 proto-oncogene; MYCL; MYCL proto-oncogene, bHLH transcription factor; Mycl1; myc-related gene from lung cancer; Protein L-Myc; protein L-Myc-1; v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog; V-myc myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived; v-myc myelocytomatosis viral oncogene homolog, lung carcinoma derived (avian) | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 4610 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction